Costa Rica vs Rwanda: Cause of death, by non-communicable diseases, ages 60+
Costa Rica
71.3%
in 2021
Rwanda
71.2%
in 2021
Costa Rica rank
95th
Rwanda rank
97th
Cause of death, by non-communicable diseases, ages 60+ over time
- Costa Rica
- Rwanda
How they compare
Costa Rica currently reports 71.3% against 71.2% in Rwanda, a difference of 0.1%.
Across all 6 years both countries report, Costa Rica has been ahead every year.
Costa Rica ranks 95th and Rwanda ranks 97th of 185 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.6% | 71.1% | 18.5% | Costa Rica |
| 2010s | 90.0% | 74.2% | 15.8% | Costa Rica |
| 2020s | 77.5% | 73.4% | 4.1% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Costa Rica or Rwanda?
- Costa Rica, at 71.3% against 71.2% in Rwanda as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Costa Rica and Rwanda?
- 0.1%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Rwanda?
- 6 years are reported by both, from 2000 to 2021.
- How do Costa Rica and Rwanda rank globally for cause of death, by non-communicable diseases, ages 60+?
- Costa Rica ranks 95th and Rwanda ranks 97th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.